You are here:

Tigecycline 50mg vial of powder tigecycline for intravenous infusion (Tygacil®)

Advice

Following a full submission.

Tigecycline (Tygacil) is accepted for restricted use within NHS Scotland for the treatment of complicated intra-abdominal infection.

Tigecycline is associated with clinical cure rates in patients with complicated intra-abdominal infections non-inferior to those with a broad-spectrum beta-lactam antibiotic. It is restricted to 2nd line use under the advice of local microbiologists or specialists in infectious disease.

Drug Details

Drug Name: Tigecycline 50mg vial of powder tigecycline for intravenous infusion (Tygacil®)
SMC Drug ID: 277/06
Manufacturer: Wyeth Pharmaceuticals
Indication: Complicated intra-abdominal infection
BNF Category:
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 July 2006

Back